Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scilex Holding (SCLX) Current Deferred Revenue (2022 - 2025)

Scilex Holding has reported Current Deferred Revenue over the past 4 years, most recently at $407000.0 for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 8.95% year-over-year to $407000.0; the TTM value through Dec 2025 reached $407000.0, down 8.95%, while the annual FY2025 figure was $407000.0, 8.95% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $407000.0 at Scilex Holding, down from $417000.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $516000.0 in Q2 2023 and troughed at $264000.0 in Q4 2022.
  • A 4-year average of $439000.0 and a median of $447000.0 in 2024 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: surged 85.98% in 2023 and later dropped 9.11% in 2024.
  • Year by year, Current Deferred Revenue stood at $264000.0 in 2022, then surged by 85.98% to $491000.0 in 2023, then dropped by 8.96% to $447000.0 in 2024, then decreased by 8.95% to $407000.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for SCLX at $407000.0 in Q4 2025, $417000.0 in Q3 2025, and $427000.0 in Q2 2025.